{"slideshow_credits": null, "snippet": "The state attorney general said Actavis\u2019s plan to stop selling an older tablet in favor of a newer one was an attempt to maintain a monopoly.", "abstract": "New York Attorney Gen Eric T Schneiderman files antitrust lawsuit seeking to stop pharmaceutical company Actavis from forcing patients with Alzheimer's disease to switch to new version of its widely used drug Namenda; argues move is attempt to blunt competition from low-priced generic versions.", "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/09/16/business/new-york-files-antitrust-suit-against-maker-of-alzheimers-drug.html", "lead_paragraph": "The state attorney general said Actavis\u2019s plan to stop selling an older tablet in favor of a newer one was an attempt to maintain a monopoly.", "headline": {"seo": "Forest Laboratories' Namenda Is Focus of Lawsuit", "main": "New York Files an Antitrust Suit Against the Maker of an Alzheimer&#8217;s Drug ", "print_headline": "New York Files an Antitrust Suit Against the Maker of an Alzheimer\u2019s Drug"}, "_id": "5417745638f0d851fd3a7fb6", "word_count": "1074", "multimedia": [{"height": 126, "url": "images/2014/09/16/business/Generic1/Generic1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/09/16/business/Generic1/Generic1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/09/16/business/Generic1/Generic1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/09/16/business/Generic1/Generic1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/09/16/business/Generic1/Generic1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/09/16/business/Generic1/Generic1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-09-16T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Actavis Group", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Alzheimer's Disease", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Schneiderman, Eric T", "name": "persons", "is_major": "Y", "rank": "3"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "New York State", "name": "glocations", "is_major": "N", "rank": "7"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "8"}, {"value": "Forest Laboratories Inc", "name": "organizations", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}